Santhera Pharmaceuticals (SPHDF) Q3 2024 Earnings

12SepConfirmed
Mar 21
Jun 21
Q2 2024
Q3 2024
-1.5
-1
-0.5
0

Details

Expected EPS
N/A
Actual EPS
-1.501605
Surprise EPS
-1.5
Surprise Percent
+∞%

Description

Santhera Pharmaceuticals (SPHDF) has reported earnings of -1.501605 per share for Q3 2024.

0 Comments

Share your thoughts